These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 5362211)
1. [Theoretical observations on the optimization of the "weakening" attack within the scope of multiple-step therapy of cancer. Pharmacokinetic principle for the selective transport of cytotoxin into cancer tissue]. von Ardenne M; Reitnauer PG Z Arztl Fortbild (Jena); 1969 Sep; 63(18):965-70. PubMed ID: 5362211 [No Abstract] [Full Text] [Related]
2. [In vivo studies on multiple-step cancer therapy using immune antibodies for attack induction. Variant for metastasis treatment]. von Ardenne M; Chaplain RA; Prokop O Dtsch Gesundheitsw; 1969 Aug; 24(34):1589-93. PubMed ID: 5376219 [No Abstract] [Full Text] [Related]
3. [In vivo studies on cancer multiple-step therapy using the attack combination of optimum tumor overacidification, hyperthermia and weak X-irradiation]. von Ardenne M; Chaplain RA; Reitnauer PG Dtsch Gesundheitsw; 1969 May; 24(20):924-35. PubMed ID: 5375903 [No Abstract] [Full Text] [Related]
4. [In vitro studies on the induction of an immunochemical attack using anti-AHP in the scope of cancer multiple-step therapy]. von Ardenne M; Krüger W; Prokop O; Schnitzler S Dtsch Gesundheitsw; 1969 Mar; 24(13):588-94. PubMed ID: 4913012 [No Abstract] [Full Text] [Related]
5. [Measurements on selective damage to cancer cells in vitro by attack-combination with hyperacidification plus 40 degree C hyperthermia and various bile acids with favorable pH]. von Ardenne M; Reitnauer PG Arzneimittelforschung; 1970 Mar; 20(3):323-9. PubMed ID: 5467505 [No Abstract] [Full Text] [Related]
6. [Problems of multiple step-therapy of carcinoma. I. On the history of hyperthermic treatment]. Kirsch R; Schmidt D; Schmidt H Dtsch Gesundheitsw; 1967 Apr; 22(15):678-81 contd. PubMed ID: 5590967 [No Abstract] [Full Text] [Related]
7. Biologic product with an inhibitory effect on an experimental neoplastic disease. Komis A; Petrescu A; Athanasiu P; Stoian M Rev Roum Inframicrobiol; 1971; 8(4):281-2. PubMed ID: 4949056 [No Abstract] [Full Text] [Related]
8. [Experimental and clinical studies of hyperthermochemotherapy (author's transl)]. Maeta M; Hirai Y; Hamazoe R; Shimizu N; Tanida O; Koga S Nihon Gan Chiryo Gakkai Shi; 1979 Feb; 14(1):1-9. PubMed ID: 438576 [No Abstract] [Full Text] [Related]
9. Biology of local heat therapy for cancer. Babbs CF Med Instrum; 1982; 16(1):23-6. PubMed ID: 7062865 [TBL] [Abstract][Full Text] [Related]
10. [In vivo experiments on the multistage cancer therapy with "triggering" attack by vitamin A plus dimethyl sulfoxide]. von Ardenne M; Chaplain RA Z Gesamte Inn Med; 1969 Sep; 24(18):609-13. PubMed ID: 5368137 [No Abstract] [Full Text] [Related]
11. [Selective in vivo thermosensitization and therapy of the Ehrlich-mouse-ascites carcinoma with vitamin K 3 sodium bisulfite]. von Ardenne M; Reitnauer PG Dtsch Gesundheitsw; 1967 Oct; 22(40):1879-85. PubMed ID: 5600833 [No Abstract] [Full Text] [Related]
12. [On the toxicology of the attack combination of tumor hyperacidification, Tween 80, ethyl alcohol, diethylstilbestrol, vitamin K3 and 40 degrees C-hyperthermia in cancer multi-step therapy]. von Ardenne M; Reitnauer PG Arzneimittelforschung; 1968 Jun; 18(6):666-76. PubMed ID: 5755802 [No Abstract] [Full Text] [Related]
13. [Problems of multiple step-therapy of carcinoma. II. Effect of hyperthermia on cancer tissue]. Kirsch R; Schmidt D; Fichler J; Schmidt H Dtsch Gesundheitsw; 1967 Apr; 22(16):732-5. PubMed ID: 5587080 [No Abstract] [Full Text] [Related]
14. [In vitro study for shortening of hyperthermia duration in multi-step cancer therapy. Release of lysosomal cytolysis chain reaction by over-acidification and hyperthermia and its continuation after cessation of hyperthermia]. von Ardenne M; Reitnauer PG Arch Geschwulstforsch; 1971; 38(3):264-9. PubMed ID: 5144207 [No Abstract] [Full Text] [Related]
15. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells. Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114 [TBL] [Abstract][Full Text] [Related]
16. The combined effect of 6-azauridine and irradiation in vivo and in vitro. I. The acute effect on the mouse Ehrlich ascitic carcinoma. Grozdanovic J; Vích Z; Truxová G Neoplasma; 1968; 15(3):247-9. PubMed ID: 5695133 [No Abstract] [Full Text] [Related]
17. [Role of virus inhibitory factor or interferon in the antitumoral effect of whole-body hyperthermia]. Nakamura W; Nagano Y; Otsuka K; Nishimoto Y C R Seances Soc Biol Fil; 1980; 174(1):104-7. PubMed ID: 6160896 [TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy? Sautter-Bihl ML; Bihl H Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292 [TBL] [Abstract][Full Text] [Related]
19. Temperature dependency of anti-cancer chemotherapeutic effect. Hara T Kumamoto Med J; 1969 Sep; 22(3):140-9. PubMed ID: 5370528 [No Abstract] [Full Text] [Related]
20. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy. Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]